Sapna Srivastava

Insider Reports History

Location
Cedar Knolls, NJ
Signature
/s/ Brad Middlekauff, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sapna Srivastava:

Company Role Class Num Shares Value Price $ Report Date Ownership
Innoviva, Inc. Director Common Stock 44,096 $711,268 $16.13 17 Jun 2024 Direct
Nuvalent, Inc. Director Class A Common Stock 5,146 $343,341 $66.72 18 Jun 2025 Direct
Aura Biosciences, Inc. Director Common Stock 23,500 $125,725 $5.35 17 Jun 2025 Direct
Tourmaline Bio, Inc. Director Common Stock 0 $0 $47.83 28 Oct 2025 Direct
ALUMIS INC. Director Stock Option (Right to Buy) 49,800 30 Jul 2025 Direct
SQZ Biotechnologies Co Director Stock Option 39,875 14 Jun 2023 Direct
Innoviva, Inc. Director Non-statutory Stock Option 22,500 17 Jun 2024 Direct
Aura Biosciences, Inc. Director Stock Option (Right to Buy) 17,000 17 Jun 2025 Direct
Tourmaline Bio, Inc. Director Stock Option (Right to Buy) 16,800 04 Jun 2025 Direct
Nuvalent, Inc. Director Stock Option (Right to Buy) 4,147 18 Jun 2025 Direct
Tourmaline Bio, Inc. Director Employee Stock Option (Right to Buy) 0 28 Oct 2025 Direct

Insider Reports Filed by Sapna Srivastava

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TRML Tourmaline Bio, Inc. 28 Oct 2025 4 $0 4 Director 28 Oct 2025, 18:30
ALMS ALUMIS INC. 30 Jul 2025 1 $0 4 Director 01 Aug 2025, 16:05
NUVL Nuvalent, Inc. 18 Jun 2025 2 $0 4 Director 20 Jun 2025, 16:39
AURA Aura Biosciences, Inc. 17 Jun 2025 2 $0 4 Director 18 Jun 2025, 16:10
TRML Tourmaline Bio, Inc. 04 Jun 2025 1 $0 4 Director 06 Jun 2025, 16:36
ALMS ALUMIS INC. 27 Jun 2024 5 $0 4 Director 01 Jul 2024, 16:42
ALMS ALUMIS INC. 27 Jun 2024 0 $0 3 Director 27 Jun 2024, 16:10
AURA Aura Biosciences, Inc. 20 Jun 2024 2 $0 4 Director 24 Jun 2024, 16:08
INVA Innoviva, Inc. 17 Jun 2024 2 $0 4 Director 20 Jun 2024, 17:01
NUVL Nuvalent, Inc. 12 Jun 2024 2 $0 4 Director 14 Jun 2024, 16:15
TRML Tourmaline Bio, Inc. 05 Jun 2024 1 $0 4 Director 07 Jun 2024, 16:02
TRML Tourmaline Bio, Inc. 19 Oct 2023 3 $0 4 Director 23 Oct 2023, 20:31
NUVL Nuvalent, Inc. 15 Jun 2023 1 $0 4 Director 16 Jun 2023, 16:22
/report/000120919123037388-srivastava-sapna-2023-06-14 SQZ Biotechnologies Co 14 Jun 2023 1 $0 4 Director 15 Jun 2023, 16:47
TRML Talaris Therapeutics, Inc. 13 Jun 2023 1 $0 4 Director 14 Jun 2023, 19:03
AURA Aura Biosciences, Inc. 07 Jun 2023 1 $0 4 Director 09 Jun 2023, 16:54
INVA Innoviva, Inc. 22 May 2023 2 $0 4 Director 24 May 2023, 17:57
INVA Innoviva, Inc. 01 Jan 2023 0 $0 3 Director 06 Jan 2023, 16:05
NUVL Nuvalent, Inc. 16 Jun 2022 1 $0 4 Director 17 Jun 2022, 16:21
AURA Aura Biosciences, Inc. 15 Jun 2022 1 $0 4 Director 17 Jun 2022, 17:07
/report/000120919122037480-srivastava-sapna-2022-06-15 SQZ Biotechnologies Co 15 Jun 2022 1 $0 4 Director 16 Jun 2022, 17:00
TRML Talaris Therapeutics, Inc. 09 Jun 2022 1 $0 4 Director 13 Jun 2022, 18:11
AURA Aura Biosciences, Inc. 28 Oct 2021 1 $0 4 Director 29 Oct 2021, 19:18
AURA Aura Biosciences, Inc. 28 Oct 2021 0 $0 3 Director 28 Oct 2021, 20:26
NUVL Nuvalent, Inc. 28 Jul 2021 1 $0 4 Director 30 Jul 2021, 17:03
NUVL Nuvalent, Inc. 28 Jul 2021 0 $0 3 Director 28 Jul 2021, 21:34
/report/000120919121043831-srivastava-sapna-2021-06-29 Social Capital Suvretta Holdings Corp. II 29 Jun 2021 0 $0 3 Director 29 Jun 2021, 20:08
/report/000120919121041539-srivastava-sapna-2021-06-15 SQZ Biotechnologies Co 15 Jun 2021 1 $0 4 Director 17 Jun 2021, 17:16